- Home
- LGO vs BMEA Comparison
LGO vs BMEA Comparison
Compare LGO & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGO
- BMEA
- Stock Information
- Founded
- LGO 1988
- BMEA 2017
- Country
- LGO Canada
- BMEA United States
- Employees
- LGO N/A
- BMEA N/A
- Industry
- LGO
- BMEA Biotechnology: Pharmaceutical Preparations
- Sector
- LGO
- BMEA Health Care
- Exchange
- LGO Nasdaq
- BMEA Nasdaq
- Market Cap
- LGO 109.0M
- BMEA 125.4M
- IPO Year
- LGO 2007
- BMEA 2021
- Fundamental
- Price
- LGO $1.65
- BMEA $2.18
- Analyst Decision
- LGO Strong Buy
- BMEA Buy
- Analyst Count
- LGO 1
- BMEA 13
- Target Price
- LGO $3.70
- BMEA $27.92
- AVG Volume (30 Days)
- LGO 78.1K
- BMEA 689.7K
- Earning Date
- LGO 05-14-2025
- BMEA 05-01-2025
- Dividend Yield
- LGO N/A
- BMEA N/A
- EPS Growth
- LGO N/A
- BMEA N/A
- EPS
- LGO N/A
- BMEA N/A
- Revenue
- LGO $124,920,000.00
- BMEA N/A
- Revenue This Year
- LGO N/A
- BMEA N/A
- Revenue Next Year
- LGO $33.05
- BMEA N/A
- P/E Ratio
- LGO N/A
- BMEA N/A
- Revenue Growth
- LGO N/A
- BMEA N/A
- 52 Week Low
- LGO $1.38
- BMEA $2.27
- 52 Week High
- LGO $2.84
- BMEA $16.29
- Technical
- Relative Strength Index (RSI)
- LGO 41.53
- BMEA 31.71
- Support Level
- LGO $1.75
- BMEA $2.27
- Resistance Level
- LGO $1.87
- BMEA $3.08
- Average True Range (ATR)
- LGO 0.08
- BMEA 0.23
- MACD
- LGO -0.01
- BMEA 0.03
- Stochastic Oscillator
- LGO 9.38
- BMEA 3.72
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The Company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The Company has six operating segments: sales & trading wich generates key revenue, mine properties, corporate, exploration and evaluation properties, Largo Clean Energy, and Largo Physical Vanadium.
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.